William Mack & Associates
MRK icon

William Mack & Associates’s Merck MRK Stock Holding History

William Mack & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$159K Buy
+1,091
New +$151K 0.05% 126

Other funds holding MRK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

William Mack & Associates's MRK Position: Q3 2026 in Review

William Mack & Associates opened a new position in Merck (MRK) in Q3 2026: 1,091 shares worth $159K. The stake represents 0.05% of the portfolio and ranks #126 among its holdings.

3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • William Mack & Associates held 1,091 shares of Merck worth $159K as of Q3 2026.
  • Merck was a new William Mack & Associates position in Q3 2026.
  • Merck made up 0.05% of William Mack & Associates's portfolio in Q3 2026, its #126 holding.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.